NEW YORK, NY — As the calendar turns to October, the global skyline begins its familiar transformation into a sea of pink. While Breast Cancer Awareness Month often focuses on early detection, screening, and survivorship, a critical and often overlooked reality persists in the shadows: Metastatic Breast Cancer (MBC). On October 13, National Metastatic Breast Cancer Awareness Day, the nonprofit organization METAvivor is set to change that narrative through its monumental global campaign, #LightUpMBC.
With more than 325 landmarks across 20 countries and 195 cities preparing to illuminate in the signature colors of teal, green, and pink, the initiative serves as both a solemn tribute to those lost to the disease and a urgent call to action for the scientific funding necessary to turn a terminal diagnosis into a manageable, long-term condition.
The Reality of Stage 4: Defining the Crisis
Metastatic breast cancer, or Stage 4, occurs when cancer cells spread from the primary site in the breast to distant organs, most commonly the bones, liver, lungs, or brain. It is vital to understand that even when cancer appears in another organ, it is still classified as breast cancer.
For many, this diagnosis is a life-altering shock, whether it occurs at the initial onset of disease or as a recurrence years after a patient was told they were “cancer-free.” Unlike early-stage breast cancer, which may be treated with the hope of a cure, MBC is currently incurable. Patients face a lifelong journey of rotating through various treatments, from chemotherapy and targeted therapies to immunotherapy, all designed to control the disease, extend life, and preserve quality of life.
The statistics are sobering. In the United States alone, an estimated 42,670 people are expected to lose their lives to breast cancer in 2026—an average of 117 people every single day. This data underscores the urgency of the METAvivor mission: to bridge the gap between current palliative care and the ultimate goal of transforming MBC into a survivable chronic condition.
A Chronology of Advocacy: From One Bridge to a Global Movement
The #LightUpMBC campaign traces its roots back to a deeply personal mission. In 2017, the Portsmouth Memorial Bridge in New Hampshire became the first structure in the world to light up for metastatic breast cancer awareness. This singular act of remembrance was spearheaded by Laura Inahara, who sought to honor her best friend, Jessica Moore, who tragically lost her battle with MBC at the age of 36.
- 2017: The inaugural lighting of the Portsmouth Memorial Bridge marks the genesis of the campaign.
- 2018–2020: The movement gains momentum as local advocates across the U.S. petition their city councils and landmark operators to participate, expanding the scope of the "teal, green, and pink" light displays.
- 2021–2025: #LightUpMBC evolves into a sophisticated global digital and physical event, integrating live-streaming technology to connect patients, researchers, and families during the height of the pandemic and beyond.
- 2026: The campaign reaches its most expansive reach to date, encompassing over 325 international landmarks, including iconic structures like One World Trade Center, the Willis Tower, Niagara Falls, and the Ness Bridge in Scotland.
What began as a localized effort to honor a life cut short has since evolved into a powerful engine for philanthropy, raising over $2.7 million for critical research to date.
The Science of Survival: METAvivor’s Rigorous Approach
While awareness is the first step, METAvivor differentiates itself through its uncompromising commitment to funding research. The organization exclusively supports Stage 4 research, a niche that remains chronically underfunded in the broader oncology landscape.
METAvivor employs a two-tiered review process to ensure that every dollar raised is directed toward the most promising scientific endeavors:
- Scientific Peer Review: Applications are scrutinized by a panel of expert researchers to ensure methodology, viability, and potential impact on patient outcomes.
- Patient Advocate Review: This unique step ensures that the proposed research aligns with the real-world needs and priorities of those living with the disease.
By prioritizing projects that aim to disrupt the progression of cancer and extend the lifespan of patients, METAvivor is filling a critical void in clinical research. As the organization notes, when patients become resistant to one therapy—a common occurrence in metastatic disease—they must move to the next. The goal of METAvivor’s research portfolio is to ensure that there is always a "next" treatment available.
Voices from the Frontlines: Official Perspectives
The impact of the #LightUpMBC campaign is best understood through the voices of those leading the charge. Dr. Kelly Shanahan, the Board President of METAvivor, has lived with an MBC diagnosis since 2013.
"When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan remarked. "My hope and the hope of so many others lies in research. METAvivor-funded research is increasingly important these days, and #LightUpMBC is the single biggest contributor to this work. More than just a fundraiser, it is the glue that holds our community together."
The founder of the campaign, Laura Inahara, reflects on the legacy of her friend, Jessica Moore: "Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teaches patients how to advocate for themselves, and has now raised over $2.7 million for research. She would be proud to see how far this has come."
LightUpMBC Live: A Global Broadcast
The pinnacle of the October 13 awareness day is the #LightUpMBC Live event, a broadcast designed to humanize the statistics. Hosted by Tami Eagle Bowling, an 11-year survivor of metastatic breast cancer, and Broadway star Kara Lindsay, the event promises to be a powerful blend of advocacy and art.
Program Highlights:
- Patient Stories: Personal accounts shared live from illuminated landmarks across the globe, providing a voice to the millions living with Stage 4.
- Scientific Insights: Experts will discuss the latest breakthroughs in metastatic research and the hurdles that remain in clinical development.
- Musical Performances: The broadcast will feature performances from Tony Award winner Victoria Clark, Dorian Harewood, Christina Bianco, Cassandra Kubinski, and Tony Daniels.
The broadcast will be available for free at 8 p.m. ET / 5 p.m. PT via the METAvivor YouTube channel, Facebook Live, and the LiveOne platform. One hundred percent of the net proceeds from the campaign and the event will be funneled directly into METAvivor’s research grant fund.
Implications: Moving Beyond Awareness to Action
The implications of the #LightUpMBC movement are twofold. First, it challenges the societal stigma and misunderstanding surrounding metastatic cancer. By illuminating landmarks, the campaign forces the public to confront the existence of a disease that is often relegated to private suffering.
Second, it provides a direct lifeline to the scientific community. By funding the research that "big pharma" or traditional grants might overlook, METAvivor acts as a venture capitalist for life-saving science. As the medical community works toward the goal of making MBC a survivable condition, the funds raised on October 13 are not just money—they are time.
"We aren’t just lighting up the world for a night," says Tami Eagle Bowling. "We are lighting a path toward a future where a metastatic diagnosis is no longer a death sentence."
For those wishing to support the mission, the organization encourages the public to visit www.lightupmbc.org to view the list of participating landmarks, donate, or access the live stream links. As the sun sets on October 13, the sight of hundreds of cities glowing in teal, green, and pink will stand as a powerful testament to human resilience and the collective demand for a cure.
About the Author
